These authors engineered exosomes from adipose tissue-derived stem cells (ADSCs) to overexpress Sirtuin 1 (SIRT1) and treated circulating EPCs isolated from MI patients, thus enhancing their cell migratory capacity. Here, SIRT1 is linked to myocardial infarction.